Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leiomyoma × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 7 Lung Neoplasms 5 Head and Neck Neoplasms 5 Neoplasms 4 Leukemia, Myeloid, Acute 4 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Recurrence 2 Pulmonary Disease, Chronic Obstructive 2 Neoplasm Metastasis 2 Leukemia 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Xerostomia 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Teratoma 1 Stroke 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Diseases 1

Interventions

vilaprisan 6 ulipristal acetate 6 asoprisnil 6 telapristone acetate 5 relugolix 5 estradiol, norethindrone drug combination 5 linzagolix 4 elagolix 4 Estradiol 4 Norethindrone Acetate 3 Progestins 2 epigallocatechin gallate 1 Uterine Myomectomy 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Tea 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Saline Solution 1 Misoprostol 1 Mifepristone 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Leuprolide 1 Laparoscopy 1 Iron 1 Hysterectomy 1 Goserelin 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03194646 2025-07-28

ASTEROID 6

Bayer

Phase 3 Terminated

1,272 enrolled 16 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡